专利检索 ap:("Sanofi" OR "Innate Pharma") AND inv:"VIRONE-ODDOS, Angela" 第 1 页

1.

发明公开
MULTIFUNCTIONAL NATURAL KILLER (NK) CELL ENGAGERS BINDING TO NKP46 AND CD123 审中-公开

公开(公告)号：EP4271709A1

公开(公告)日：2023-11-08

申请号：EP21840696.5

申请日：2021-12-30

申请人： Sanofi , Innate Pharma

发明人： GAUTHIER, Laurent , THIELENS, Ariane , ROSSI, Benjamin , AMARA, Céline , NICOLAZZI, Céline , CHIRON, Marielle , DUFFIEUX, Francis , VIRONE-ODDOS, Angela , BENINGA, Jochen

IPC分类号： C07K16/28 , A61P35/02 , A61K39/395 , A61P35/00

2.

发明公开
ANTI-CD38 ANTIBODIES AND FORMULATIONS 审中-公开

公开(公告)号：EP3958898A1

公开(公告)日：2022-03-02

申请号：EP20726267.6

申请日：2020-04-23

申请人： SANOFI

发明人： CAMERON, Béatrice , CHIRON BLONDEL, Marielle , DUMAS, Jacques , FOURNIER, Alain , KINGSBURY, Jonathan , LEMOINE, Cendrine , MURRAY, Brian , OSTBERG, Nathan , PATKE, Sanket , VIRONE-ODDOS, Angela , ZHANG, Zichuan

IPC分类号： A61K39/395 , C07K16/28 , A61P35/00 , A61K39/00

3.

发明公开
ANTI-TUMORAL COMPOSITION COMPRISING A PI3KBETA-SELECTIVE INHIBITOR AND A PI3KALPHA-SELECTIVE INHIBITOR 审中-公开
标题翻译： WITH A PI3KBETA选择性抑制剂AND A PI3KALPHA选择性抑制剂抗肿瘤药物组合物

公开(公告)号：EP2981261A1

公开(公告)日：2016-02-10

申请号：EP14714736.7

申请日：2014-04-03

申请人： SANOFI

发明人： BONNEVAUX, Hélène , GARCIA-ECHEVERRIA, Carlos , VIRONE-ODDOS, Angela

IPC分类号： A61K31/4439 , A61K31/513 , A61K45/06 , A61P35/00

CPC分类号： A61K31/5377 , A61K31/4439 , A61K31/513 , A61K45/06 , A61K2300/00

摘要： The present invention concerns a combination of a PI3Kβ selective inhibitor with a PI3Kα selective inhibitor for use in the treatment of cancer.

4.

发明公开
ANTI-TUMORAL COMPOSITION COMPRISING A PI3KBETA INHIBITOR AND A RAF INHIBITOR, TO OVERCOME CANCER CELLS RESISTANCE 审中-公开
标题翻译：与β抑制剂PI3K和RAF抑制剂克服癌细胞抵抗抗肿瘤药物组合物

公开(公告)号：EP2968350A1

公开(公告)日：2016-01-20

申请号：EP14710274.3

申请日：2014-03-14

申请人： SANOFI

发明人： BONNEVAUX, Hélène , GARCIA-ECHEVERRIA, Carlos , VIRONE-ODDOS, Angela

IPC分类号： A61K31/538 , A61K31/437 , A61P35/00

CPC分类号： A61K31/5377 , A61K31/437 , A61K31/5375 , A61K45/06 , G01N33/5011 , G01N33/5017 , G01N33/57496 , A61K2300/00

摘要： The present invention concerns a combination of a ΡΙ3Κβ inhibitor with a RAF inhibitor for its use for the treatment of a patient resistant to at least one RAF inhibitor, a kit comprising the same, its pharmaceutical uses thereof and a method of monitoring the efficiency of said combination when administered to a patient.

5.

发明公开
COMPOSITIONS AND METHODS FOR TREATING CANCER USING PI3K BETA INHIBITOR AND MAPK PATHWAY INHIBITOR, INCLUDING MEK AND RAF INHIBITORS 审中-公开
标题翻译：组合物和方法用于治疗癌症使用PI3K抑制剂和β-MAPK-线列车抑制剂，包括MEK和RAF抑制剂

公开(公告)号：EP2755653A1

公开(公告)日：2014-07-23

申请号：EP12759137.8

申请日：2012-09-14

申请人： SANOFI

发明人： GARCIA-ECHEVERRIA, Carlos , VINCENT, Loïc , VIRONE-ODDOS, Angela

IPC分类号： A61K31/4184 , A61K31/437 , A61K31/5377 , A61K45/06 , A61P35/00

CPC分类号： A61K31/5377 , A61K31/4184 , A61K31/437 , A61K45/06 , A61K2300/00

摘要： The present invention relates to compositions comprising at least one MAPK pathway inhibitor including MEK and RAF inhibitors and at least one ΡΙ3Κβ inhibitor, and also to uses thereof for the treatment of cancer.